The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The Mycobacterial Cell Envelope--Lipids
Open accessAbstract
Mycobacterium tuberculosis (Mtb) lipids are indelibly imprinted in just about every key aspect of tuberculosis (TB) basic and translational research. Although the interest in these compounds originally stemmed from their abundance, structural diversity, and antigenicity, continued research in this field has been driven by their important contribution to TB pathogenesis and their interest from the perspective of drug, vaccine, diagnostic, and biomarker development. This article summarizes what is known of the roles of lipids in the physiology and pathogenicity of Mtb and the exciting developments that have occurred in recent years in identifying new lead compounds targeting their biogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brennan, P. J., & Nikaido, H. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000333 · Cited by 1,985
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., & Yamasaki, S. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091750 · Cited by 792
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Peyron, P., Vaubourgeix, J., Poquet, Y., Levillain, F., Botanch, C., Bardou, F., Daffé, M., Emile, J.-F., Marchou, B., Cardona, P.-J., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000204 · Cited by 751
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
Daffé, M., & Draper, P. (1997) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60016-8 · Cited by 730
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Glickman, M. S., Cox, J. S., & Jacobs, W. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80250-6 · Cited by 655
Hoffmann, C., Leis, A., Niederweis, M., Plitzko, J. M., & Engelhardt, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709530105 · Cited by 596
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
Mycolic acids: structure, biosynthesis and physiological functions
Barry, C. E., Lee, R. E., Mdluli, K., Sampson, A. E., Schroeder, B. G., Slayden, R. A., & Yuan, Y. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00008-3 · Cited by 565
Tahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504
Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
Zuber, B., Chami, M., Houssin, C., Dubochet, J., Griffiths, G., & Daffé, M. (2008) · Journal of Bacteriology · doi:10.1128/jb.01919-07 · Cited by 458
Graham, J. E., & Clark-Curtiss, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11554 · Cited by 450
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Grzegorzewicz, A. E., Pham, H., Gundi, V. A. K. B., Scherman, M. S., North, E. J., Hess, T., Jones, V., Gruppo, V., Born, S. E. M., Korduláková, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.794 · Cited by 442
Self-citationIntracellular Mycobacterium tuberculosis Exploits Host-derived Fatty Acids to Limit Metabolic Stress
Lee, W., VanderVen, B. C., Fahey, R. J., & Russell, D. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445056 · Cited by 424
Ojha, A., Anand, M., Bhatt, A., Kremer, L., Jacobs, W. R., & Hatfull, G. F. (2005) · Cell · doi:10.1016/j.cell.2005.09.012 · Cited by 422
Walters, S. B., Dubnau, E., Kolesnikova, I., Laval, F., Daffe, M., & Smith, I. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05102.x · Cited by 387
Analysis of the Phthiocerol Dimycocerosate Locus ofMycobacterium tuberculosis
Camacho, L. R., Constant, P., Raynaud, C., Lanéelle, M.-A., Triccas, J. A., Gicquel, B., Daffé, M., & Guilhot, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100662200 · Cited by 382
Daniel, J., Deb, C., Dubey, V. S., Sirakova, T. D., Abomoelak, B., Morbidoni, H. R., & Kolattukudy, P. E. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.15.5017-5030.2004 · Cited by 362
STUDIES ON THE VIRULENCE OF TUBERCLE BACILLI
Bloch, H. (1950) · Journal of Experimental Medicine · doi:10.1084/jem.91.2.197 · Cited by 339
Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice
Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M., Yu, K., Quémard, A., Smith, I., & Daffé, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01882.x · Cited by 335
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Christophe, T., Jackson, M., Jeon, H. K., Fenistein, D., Contreras-Dominguez, M., Kim, J., Genovesio, A., Carralot, J.-P., Ewann, F., Kim, E. H., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000645 · Cited by 329
Self-citationSingh, A., Crossman, D. K., Mai, D., Guidry, L., Voskuil, M. I., Renfrow, M. B., & Steyn, A. J. C. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000545 · Cited by 326
Sani, M., Houben, E. N. G., Geurtsen, J., Pierson, J., de Punder, K., van Zon, M., Wever, B., Piersma, S. R., Jiménez, C. R., Daffé, M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000794 · Cited by 311
Supply, P., Marceau, M., Mangenot, S., Roche, D., Rouanet, C., Khanna, V., Majlessi, L., Criscuolo, A., Tap, J., Pawlik, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2517 · Cited by 305
Biogenesis of the mycobacterial cell wall and the site of action of ethambutol
Mikusová, K., Slayden, R. A., Besra, G. S., & Brennan, P. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2484 · Cited by 301
Mycobacterium tuberculosis and the intimate discourse of a chronic infection
Russell, D. G. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00984.x · Cited by 291
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
Zimhony, O., Cox, J. S., Welch, J. T., Vilchèze, C., & Jacobs, W. R. (2000) · Nature Medicine · doi:10.1038/79558 · Cited by 270
Ortalo-Magné, A., Lemassu, A., Lanéelle, M. A., Bardou, F., Silve, G., Gounon, P., Marchal, G., & Daffé, M. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.2.456-461.1996 · Cited by 270
Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Sacksteder, K. A., Protopopova, M., Barry, C. E., Andries, K., & Nacy, C. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.56 · Cited by 269
Tsenova, L., Ellison, E., Harbacheuski, R., Moreira, A. L., Kurepina, N., Reed, M. B., Mathema, B., Barry III, C. E., & Kaplan, G. (2005) · The Journal of Infectious Diseases · doi:10.1086/430614 · Cited by 264
Stanley, S. A., Grant, S. S., Kawate, T., Iwase, N., Shimizu, M., Wivagg, C., Silvis, M., Kazyanskaya, E., Aquadro, J., Golas, A., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300151m · Cited by 253
Constant, P., Perez, E., Malaga, W., Lanéelle, M.-A., Saurel, O., Daffé, M., & Guilhot, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206538200 · Cited by 249
Tuberculosis biomarkers discovery: developments, needs, and challenges
Wallis, R. S., Kim, P., Cole, S., Hanna, D., Andrade, B. B., Maeurer, M., Schito, M., & Zumla, A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70034-3 · Cited by 241
Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
Ioerger, T. R., O’Malley, T., Liao, R., Guinn, K. M., Hickey, M. J., Mohaideen, N., Murphy, K. C., Boshoff, H. I. M., Mizrahi, V., Rubin, E. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075245 · Cited by 241
Reed, M. B., Gagneux, S., DeRiemer, K., Small, P. M., & Barry, C. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01670-06 · Cited by 238
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Wang, F., Sambandan, D., Halder, R., Wang, J., Batt, S. M., Weinrick, B., Ahmad, I., Yang, P., Zhang, Y., Kim, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309171110 · Cited by 228
Chapter 2 Biogenesis of the Cell Wall and Other Glycoconjugates of Mycobacterium tuberculosis
Kaur, D., Guerin, M. E., Škovierová, H., Brennan, P. J., & Jackson, M. (2009) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(09)69002-x · Cited by 226
Self-citationAsensio, J. G., Maia, C., Ferrer, N. L., Barilone, N., Laval, F., Soto, C. Y., Winter, N., Daffé, M., Gicquel, B., Martín, C., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500388200 · Cited by 223
Self-citationMmpL3 Is the Cellular Target of the Antitubercular Pyrrole Derivative BM212
La Rosa, V., Poce, G., Canseco, J. O., Buroni, S., Pasca, M. R., Biava, M., Raju, R. M., Porretta, G. C., Alfonso, S., Battilocchio, C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05270-11 · Cited by 212
Molecular composition of the outermost capsular material of the tubercle bacillus
Ortalo-Magne, A., Dupont, M.-A., Lemassu, A., Andersen, A. B., Gounon, P., & Mamadou, D. (1995) · Microbiology · doi:10.1099/13500872-141-7-1609 · Cited by 212
Definition of the First Mannosylation Step in Phosphatidylinositol Mannoside Synthesis
Korduláková, J., Gilleron, M., Mikus̃ová, K., Puzo, G., Brennan, P. J., Gicquel, B., & Jackson, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204060200 · Cited by 192
Self-citationRousseau, C., Winter, N., Pivert, E., Bordat, Y., Neyrolles, O., Ave, P., Huerre, M., Gicquel, B., & Jackson, M. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2004.00368.x · Cited by 191
Self-citationBrodin, P., Poquet, Y., Levillain, F., Peguillet, I., Larrouy-Maumus, G., Gilleron, M., Ewann, F., Christophe, T., Fenistein, D., Jang, J., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001100 · Cited by 191
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Hartkoorn, R. C., Sala, C., Neres, J., Pojer, F., Magnet, S., Mukherjee, R., Uplekar, S., Boy‐Röttger, S., Altmann, K., & Cole, S. T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201689 · Cited by 188
Division and cell envelope regulation by Ser/Thr phosphorylation: Mycobacterium shows the way
Molle, V., & Kremer, L. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.07041.x · Cited by 185
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Willand, N., Dirié, B., Carette, X., Bifani, P., Singhal, A., Desroses, M., Leroux, F., Willery, E., Mathys, V., Déprez-Poulain, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1950 · Cited by 177
Yuan, Y., Zhu, Y., Crane, D. D., & Barry III, C. E. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01026.x · Cited by 176
Tuberculosis: The drug development pipeline at a glance
Villemagne, B., Crauste, C., Flipo, M., Baulard, A. R., Déprez, B., & Willand, N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.033 · Cited by 172
Mycobacterium and the coat of many lipids
Russell, D. G., Mwandumba, H. C., & Rhoades, E. E. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205034 · Cited by 164
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
Wilson, R., Kumar, P., Parashar, V., Vilchèze, C., Veyron-Churlet, R., Freundlich, J. S., Barnes, S. W., Walker, J. R., Szymonifka, M. J., Marchiano, E., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1277 · Cited by 160
Sirakova, T. D., Dubey, V. S., Deb, C., Daniel, J., Korotkova, T. A., Abomoelak, B., & Kolattukudy, P. E. (2006) · Microbiology · doi:10.1099/mic.0.28993-0 · Cited by 158
Mycobacterium tuberculosiscell envelope lipids and the host immune response
Karakousis, P. C., Bishai, W. R., & Dorman, S. E. (2004) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00351.x · Cited by 152
Distribution of Phthiocerol Diester, Phenolic Mycosides and Related Compounds in Mycobacteria
Daffé, M., & Lanéelle, M. (1988) · Microbiology · doi:10.1099/00221287-134-7-2049 · Cited by 149
Ojha, A. K., Trivelli, X., Guérardel, Y., Kremer, L., & Hatfull, G. F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112813 · Cited by 148
Dhiman, R. K., Mahapatra, S., Slayden, R. A., Boyne, M. E., Lenaerts, A., Hinshaw, J. C., Angala, S. K., Chatterjee, D., Biswas, K., Narayanasamy, P., et al. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06625.x · Cited by 146
Alahari, A., Trivelli, X., Guérardel, Y., Dover, L. G., Besra, G. S., Sacchettini, J. C., Reynolds, R. C., Coxon, G. D., & Kremer, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001343 · Cited by 144
Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis
Neyrolles, O., & Guilhot, C. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.01.002 · Cited by 144
Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis
Lemassu, A., & Daffé, M. (1994) · Biochemical Journal · doi:10.1042/bj2970351 · Cited by 143
Structure of the major triglycosyl phenol‐phthiocerol of Mycobacterium tuberculosis (strain Canetti)
Daffé, M., Lacave, C. S., Lanéelle, M., et al. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb13317.x · Cited by 140
Goren, M. B., Brokl, O. H., & Schaefer, W. B. (1974) · Infection and Immunity · doi:10.1128/iai.9.1.142-149.1974 · Cited by 139
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen
Favrot, L., Grzegorzewicz, A. E., Lajiness, D. H., Marvin, R. K., Boucau, J., Isailović, D., Jackson, M., & Ronning, D. R. (2013) · Nature Communications · doi:10.1038/ncomms3748 · Cited by 139
Self-citationSambandan, D., Dao, D. N., Weinrick, B. C., Vilchèze, C., Gurcha, S. S., Ojha, A. K., Kremer, L., Besra, G. S., Hatfull, G. F., & Jacobs, W. R. (2013) · mBio · doi:10.1128/mbio.00222-13 · Cited by 139
Sinsimer, D., Huet, G., Manca, C., Tsenova, L., Koo, M.-S., Kurepina, N. E., Kana, B. D., Mathema, B., Marras, S. A. E., Kreiswirth, B. N., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01663-07 · Cited by 139
Remuiñán, M. J., Pérez‐Herrán, E., Rullás, J., Alemparte, C., Martínez-Hoyos, M., Dow, D. J., Afari, J., Mehta, N., Esquivias, J., Jiménez, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060933 · Cited by 137
Fukuda, T., Matsumura, T., Ato, M., Hamasaki, M., Nishiuchi, Y., Murakami, Y., Maeda, Y., Yoshimori, T., Matsumoto, S., Kobayashi, K., et al. (2013) · mBio · doi:10.1128/mbio.00472-12 · Cited by 136
Morita, Y. S., de Sena, C. B. C., Waller, R. F., Kurokawa, K., Sernee, M. F., Nakatani, F., Haites, R. E., Billman‐Jacobe, H., McConville, M. J., Maeda, Y., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604214200 · Cited by 136
Jackson, M., Stadthagen, G., & Gicquel, B. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.05.003 · Cited by 135
Self-citationKrishnan, N., Malaga, W., Constant, P., Caws, M., Chau, T. T. H., Salmons, J., Lan, N. T. N., Bang, N. D., Daffé, M., Young, D. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023870 · Cited by 133
The outer parts of the mycobacterial envelope as permeability barriers
Draper, P. (1998) · Frontiers in bioscience · doi:10.2741/a360 · Cited by 132
Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
Debnath, J., Siricilla, S., Wan, B., Crick, D. C., Lenaerts, A. J. M., Franzblau, S. G., & Kurosu, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201608g · Cited by 130
Phetsuksiri, B., Baulard, A. R., Cooper, A. M., Minnikin, D. E., Douglas, J. D., Besra, G. S., & Brennan, P. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1042 · Cited by 127
Goren, M. B., Brokl, O. H., & Schaefer, W. B. (1974) · Infection and Immunity · doi:10.1128/iai.9.1.150-158.1974 · Cited by 124
North, E. J., Jackson, M., & Lee, R. E., Jr. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612819666131118203641 · Cited by 123
Self-citationMolecular Basis of Phosphatidyl-myo-inositol Mannoside Biosynthesis and Regulation in Mycobacteria
Guerin, M. E., Korduláková, J., Alzari, P. M., Brennan, P. J., & Jackson, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.168328 · Cited by 122
Self-citationIshizaki, Y., Hayashi, C., Inoue, K., Igarashi, M., Takahashi, Y., Pujari, V., Crick, D. C., Brennan, P. J., & Nomoto, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492173 · Cited by 120
Progress in Targeting Cell Envelope Biogenesis in Mycobacterium Tuberculosis
Jackson, M., McNeil, M., & Brennan, P. J. (2013) · Future Microbiology · doi:10.2217/fmb.13.52 · Cited by 115
Self-citationPitarque, S., Larrouy-Maumus, G. J., Payré, B., Jackson, M., Puzo, G., & Nigou, J. (2008) · Tuberculosis · doi:10.1016/j.tube.2008.04.002 · Cited by 112
Self-citationNovel type-specific lipooligosaccharides from Mycobacterium tuberculosis
Daffé, M., McNeil, M., & Brennan, P. J. (1991) · Biochemistry · doi:10.1021/bi00216a011 · Cited by 111
Lipids of Pathogenic Mycobacteria: Contributions to Virulence and Host Immune Suppression
Guenin‐Macé, L., Siméone, R., & Demangel, C. (2009) · Transboundary and Emerging Diseases · doi:10.1111/j.1865-1682.2009.01072.x · Cited by 111
Villeneuve, C., Gilleron, M., Maridonneau‐Parini, I., Daffé, M., Astarie‐Dequeker, C., & Etienne, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400308-jlr200 · Cited by 108
Identification of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum
Ren, H., Dover, L. G., Islam, S. T., Alexander, D. C., Chen, J. M., Besra, G. S., & Liu, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05603.x · Cited by 106
Grzegorzewicz, A. E., Korduláková, J., Jones, V. M., Born, S. E. M., Belardinelli, J. M., Vaquie, A. M., Gundi, V. A. K. B., Madacki, J., Slama, N., Laval, F., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.400994 · Cited by 106
Self-citationLeads for antitubercular compounds from kinase inhibitor library screens
Magnet, S., Hartkoorn, R. C., Székely, R., Pató, J., Triccas, J. A., Schneider, P. A., Szántai-Kis, C., Őrfi, L., Chambon, M., Banfi, D., et al. (2010) · Tuberculosis · doi:10.1016/j.tube.2010.09.001 · Cited by 106
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids
Daffé, M., Crick, D. C., & Jackson, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0021-2013 · Cited by 105
Self-citationCD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens
Ly, D., Kasmar, A. G., Cheng, T., de Jong, A., Huang, S., Roy, S., Bhatt, A., van Summeren, R. P., Altman, J. D., Jacobs, W. R., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20120624 · Cited by 105
Compartmentalization of Lipid Biosynthesis in Mycobacteria
Morita, Y. S., Velasquez, R., Taig, E., Waller, R. F., Patterson, J. H., Tull, D., Williams, S. J., Billman-Jacobe, H., & McConville, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414181200 · Cited by 102
Poce, G., Bates, R. H., Alfonso, S., Cocozza, M., Porretta, G. C., Ballell, L., Rullás, J., Ortega, F., Logu, A. D., Agus, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056980 · Cited by 95
Beken, S. V., Dulayymi, J. R. A., Naessens, T., Koza, G., Maza-Iglesias, M., Rowles, R. R., Theunissen, C., Medts, J. D., Lanckacker, E. A., Baird, M. S., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040719 · Cited by 95
Stanley, S. A., Kawate, T., Iwase, N., Shimizu, M., Clatworthy, A. E., Kazyanskaya, E., Sacchettini, J. C., Ioerger, T. R., Siddiqi, N., Minami, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302114110 · Cited by 95
Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds
Pan, P., & Tonge, P. J. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799984535 · Cited by 93
Ferreras, J. A., Stirrett, K. L., Lu, X., Ryu, J., Soll, C. E., Tan, D. S., & Quadri, L. E. N. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.010 · Cited by 89
Passemar, C., Arbués, A., Malaga, W., Mercier, I., Moreau, F., Lepourry, L., Neyrolles, O., Guilhot, C., & Astarie‐Dequeker, C. (2013) · Cellular Microbiology · doi:10.1111/cmi.12214 · Cited by 84
Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents
Lougheed, K. E. A., Osborne, S. A., SAXTY, B. A., Whalley, D. P., Chapman, T., Bouloc, N. S., Chugh, J., Nott, T. J., Patel, D., Rowlands, V., et al. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.03.005 · Cited by 83
Rousseau, C., Turner, O. C., Rush, E., Bordat, Y., Sirakova, T. D., Kolattukudy, P. E., Ritter, S., Orme, I. M., Gicquel, B., & Jackson, M. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4684-4690.2003 · Cited by 81
Self-citationCoxon, G. D., Craig, D., Corrales, R. M., Vialla, E., Gannoun-Zaki, L., & Kremer, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053162 · Cited by 80
Ryan, G. J., Hoff, D. R., Driver, E., Voskuil, M. I., Juarrero, M. G., Basaraba, R. J., Crick, D. C., Spencer, J. S., & Lenaerts, A. J. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011108 · Cited by 79
Rousseau, C., Neyrolles, O., Bordat, Y., Giroux, S., Sirakova, T. D., Prévost, M., Kolattukudy, P. E., Gicquel, B., & Jackson, M. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00289.x · Cited by 78
Self-citationLu, X., Zhang, H., Tonge, P. J., & Tan, D. S. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.07.130 · Cited by 77
Shui, G., Bendt, A. K., Jappar, I. A., Lim, H. M., Lanéelle, M., Hervé, M., Via, L. E., Chua, G. H., Bratschi, M. W., Rahim, S. Z. Z., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100185 · Cited by 71
Warrier, T., Tropis, M., Werngren, J., Diehl, A., Gengenbacher, M., Schlegel, B., Schade, M., Oschkinat, H., Daffé, M., Hoffner, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05742-11 · Cited by 70
Vilchèze, C., Baughn, A. D., Tufariello, J. M., Leung, L. W., Kuo, M. R., Basler, C. F., Alland, D., Sacchettini, J. C., Freundlich, J. S., & Jacobs, W. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00266-11 · Cited by 69
Mannose metabolism is required for mycobacterial growth
Patterson, J. H., Waller, R. F., Jeevarajah, D., Billman‐Jacobe, H., & McConville, M. J. (2003) · Biochemical Journal · doi:10.1042/bj20021700 · Cited by 69
Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs
Uh, E., Jackson, E. R., Jose, G. S., Maddox, M. M., Lee, R. E., Lee, R. E., Jr., Boshoff, H. I., & Dowd, C. S. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.123 · Cited by 69
A Lipid Profile Typifies the Beijing Strains of Mycobacterium tuberculosis
Huet, G., Constant, P., Malaga, W., Lanéelle, M., Kremer, K., van Soolingen, D., Daffé, M., & Guilhot, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041939 · Cited by 62
Parish, T., Liu, J., Nikaido, H., & Stoker, N. G. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.24.7827-7833.1997 · Cited by 62
Lu, X., Zhou, R., Sharma, I., Li, X., Kumar, G., Swaminathan, S., Tonge, P. J., & Tan, D. S. (2011) · ChemBioChem · doi:10.1002/cbic.201100585 · Cited by 60
Chapman, T. M., Bouloc, N. S., Buxton, R. S., Chugh, J., Lougheed, K. E. A., Osborne, S. A., SAXTY, B. A., Smerdon, S. J., Taylor, D. L., & Whalley, D. P. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.107 · Cited by 58
Rajni, R., Rao, N., & Meena, L. S. (2010) · Biotechnology Research International · doi:10.4061/2011/274693 · Cited by 53
Sakamoto, K., Kim, M. J., Rhoades, E. R., Allavena, R., Ehrt, S., Wainwright, H., Russell, D. G., & Rohde, K. H. (2012) · Infection and Immunity · doi:10.1128/iai.00906-12 · Cited by 48
Nambiar, J. K., Pinto, R., Aguilo, J. I., Takatsu, K., Martı́n, C., Britton, W. J., & Triccas, J. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141903 · Cited by 47
Lipoarabinomannan Localization and Abundance during Growth of Mycobacterium smegmatis
Dhiman, R. K., Dinadayala, P., Ryan, G. J., Lenaerts, A. J. M., Schenkel, A. R., & Crick, D. C. (2011) · Journal of Bacteriology · doi:10.1128/jb.05299-11 · Cited by 47
Cardona, P.-J., Soto, C. Y., Martı́n, C., Giquel, B., Agustí, G., Guirado, E., Sirakova, T. D., Kolattukudy, P. E., Julián, E., & Luquin, M. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.06.011 · Cited by 46
CD1a, CD1b, and CD1c in Immunity Against Mycobacteria
Rhijn, I. V., Ly, D., & Moody, D. B. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6111-1_10 · Cited by 45
Li, X., Liu, N., Zhang, H., Knudson, S. E., Li, H., Lai, C., Simmerling, C. L., Slayden, R. A., & Tonge, P. J. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200141e · Cited by 41
Assay Development for Identifying Inhibitors of the Mycobacterial FadD32 Activity
Galandrin, S., Guillet, V., Rane, R., Léger, M., Radha, N., Eynard, N., Das, K. S., Balganesh, T. S., Mourey, L., Daffé, M., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057112474691 · Cited by 38
Даниленко, В. Н., Osolodkin, D. I., Александрович, Л. С., PREOBRAZHENSKAYA, M. N., & Shtil, A. A. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795589566 · Cited by 36
Simonney, N., Molina, J., Molimard, M., Oksenhendler, É., Perronne, C., & Lagrange, P. H. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01691495 · Cited by 33
A coupled assay measuring Mycobacterium tuberculosis antigen 85C enzymatic activity
Boucau, J., Sanki, A. K., Voss, B. J., Sucheck, S. J., & Ronning, D. R. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.10.018 · Cited by 31
Zhang, J., Angala, S. K., Pramanik, P. K., Li, K., Crick, D. C., Liav, A., Jóźwiak, A. P., Świeżewska, E., Jackson, M., & Chatterjee, D. (2011) · ACS Chemical Biology · doi:10.1021/cb200091m · Cited by 29
Self-citationCD1d and Natural Killer T Cells in Immunity to Mycobacterium tuberculosis
Arora, P., Foster, E. L., & Porcelli, S. A. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6111-1_11 · Cited by 28
Murillo, J. R., Ramírez, A. S., Salas‐Rangel, L. P., Helguera‐Repetto, A. C., González-y-Merchand, J. A., Soto, C. Y., & Hernández‐Pando, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058378 · Cited by 28
Afonso-Barroso, A., Clark, S. O., Williams, A., Rosa, G. T., Nóbrega, C., Silva‐Gomes, S., Vale-Costa, S., Ummels, R., Stoker, N. G., Movahedzadeh, F., et al. (2012) · Cellular Microbiology · doi:10.1111/cmi.12065 · Cited by 27
Comparison of A60 and three glycolipid antigens in an ELISA test for tuberculosis
Simonney, N., Molina, J., Molimard, M., Oksenhendler, É., & Lagrange, P. H. (1996) · Clinical Microbiology and Infection · doi:10.1016/s1198-743x(14)65145-4 · Cited by 27
Antigen 85C-mediated acyl-transfer between synthetic acyl donors and fragments of the arabinan
Sanki, A. K., Boucau, J., Ronning, D. R., & Sucheck, S. J. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9211-z · Cited by 26
Elamin, A. A., Stehr, M., Oehlmann, W., & Singh, M. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2009.10.010 · Cited by 25
Bhowruth, V., Brown, A. K., & Besra, G. S. (2008) · Microbiology · doi:10.1099/mic.0.2008/017434-0 · Cited by 24
Mycoketide: A CD1c-Presented Antigen with Important Implications in Mycobacterial Infection
Matsunaga, I., & Sugita, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/981821 · Cited by 21
Antimycobacterial Activity and Mechanism of Action of NAS-91
Gratraud, P., Surolia, N., Besra, G. S., Surolia, A., & Kremer, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00968-07 · Cited by 21
Cording, Cord Factors, and Trehalose Dimycolate
Glickman, M. S. (2014) · ASM Press eBooks · doi:10.1128/9781555815783.ch5 · Cited by 20
Vir, P., Gupta, D., Agarwal, R., & Verma, I. (2013) · Apmis · doi:10.1111/apm.12141 · Cited by 20
Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth
Yang, L., Sinha, T., Carlson, T., Keiser, T. L., Torrelles, J. B., & Schlesinger, L. S. (2013) · Glycobiology · doi:10.1093/glycob/cwt029 · Cited by 19
Biosynthesis and Roles of Phenolic Glycolipids and Related Molecules inMycobacterium tuberculosis
Guilhot, C., Chalut, C., & Daffé, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815783.ch17 · Cited by 15
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids
Daffé, M., Crick, D. C., & Jackson, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch28 · Cited by 7
Self-citationThe Constituents of the Cell Envelope and Their Impact on the Host Immune System
Britton, W. J., & Triccas, J. A. (2014) · ASM Press eBooks · doi:10.1128/9781555815783.ch16 · Cited by 4
Cited by
Vermassen, A., Leroy, S., Talon, R., Provot, C., Popowska, M., & Desvaux, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00331 · Cited by 348
MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine
Su, C.-C., Klenotic, P. A., Bolla, J. R., Purdy, G. E., Robinson, C. V., & Yu, E. W. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901346116 · Cited by 148
Cryo-EM structure and resistance landscape of M. tuberculosis MmpL3: An emergent therapeutic target
Adams, O., Deme, J. C., Parker, J. L., Fowler, P. W., Lea, S. M., & Newstead, S. (2021) · Structure · doi:10.1016/j.str.2021.06.013 · Cited by 63
Wang, S., Wang, K., Song, K., Lai, Z. W., Li, P., Li, D., Sun, Y., Mei, Y., Xu, C., & Liao, M. (2024) · Nature Communications · doi:10.1038/s41467-024-51948-9 · Cited by 18
Gupta, K. R., Gwin, C. M., Rahlwes, K. C., Biegas, K. J., Wang, C., Park, J. H., Liu, J., Swarts, B. M., Morita, Y. S., & Rego, E. H. (2019) · doi:10.1101/633768 · Cited by 1
Metadata
- Authors
- Jackson, M.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2014-08-07
- Volume
- 4
- Issue
- 10
- Pages
- a021105-a021105
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2152257820
- Cited by
- 269
- References
- 141
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.